Ede Ronald Hao Xi reduced his stake in Sing Lee Biopharmaceuticals (01801) by approximately 752,400 shares at a price of approximately HK$88.50 per share.

According to the Finance APP, the latest information from the Hong Kong Stock Exchange shows that on July 6th, Ede Ronald Hao Xi reduced his holdings of China Biotech (01801) by 752,381 shares, with a price of 88.5042 Hong Kong dollars per share, for a total amount of 66,588,900 Hong Kong dollars. After the reduction, the latest number of shares held is approximately 4,922,300 shares, with a latest shareholding ratio of 0.28%.